Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm Study of Ebastine as Adjuvant Therapy in Patients With Tumor Budding-Positive Hepatocellular Carcinoma After Curative Hepatectomy

NCT07734766 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Xi'an Jiaotong University as lead sponsor.

NCT NCT07734766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07734766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm Study of Ebastine as Adjuvant Therapy in Patients With Tumor Budding-Positive Hepatocellular Carcinoma After Curative Hepatectomy
Lead sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
March 1, 2030
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepato cellular carcinoma